NewsWhore
09-29-2010, 12:40 PM
-(Dow Jones)- AstraZeneca PLC (AZN) Wednesday announced the start of late-stage clinical studies for its new fostamatinib pill in rheumatoid arthritis.
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/39080232/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/39080232/)